BREAKINGVIEWS-Slashing US drug prices would come at a cost: podcast

Reuters
10/16
BREAKINGVIEWS-Slashing US drug prices would come at a cost: podcast

The hosts are Reuters Breakingviews columnists. The opinions expressed are their own.

By Aimee Donnellan and Jonathan Guilford

DUBLIN/NEW YORK, Oct 16 (Reuters Breakingviews) - Follow on Apple or Spotify. Listen on the Reuters app. Read the episode transcript.

Listen to the podcast

In many cases, the market charges nearly triple what others do, a discrepancy that has put President Trump on the warpath. In this Viewsroom podcast, Breakingviews columnists discuss how Americans subsidize novel treatments and how tricky it will be to spread the burden.

Follow Aimee Donnellan on LinkedIn.

Follow Jonathan Guilford on X and LinkedIn.

FURTHER READING

Big Pharma prevails in art of the drug deal

Big Pharma’s tariff win leaves lingering aches

Obesity kings’ buffet is slimmer than it looks

Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection practices. You may also visit megaphone.fm/adchoices to opt-out of targeted advertising.

(Editing by Sheryl Peña and Gregory Garner; Production by Aditya Srivastav)

((katrina.hamlin@thomsonreuters.com))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10